Abstract
Merseburger, Bellmunt, Jenkins et al. respond to Dr. Luzzatto’s letter regarding the use of the term “castration resistant” in describing the progression of prostate cancer.
MeSH terms
-
Androgen Antagonists / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Humans
-
Male
-
Neoplasm Metastasis / drug therapy*
-
Prostatic Neoplasms, Castration-Resistant / drug therapy*